ArticleNeuropsychiatric disease and treatment2025
Oxidative Imbalance in Conversion Disorder: Evidence from Thiol-Disulphide Homeostasis Disruption.
Article in Neuropsychiatric disease and treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Conversion Disorder (CD) is a complex neuropsychiatric condition in which stress-related biological changes are thought to play a role. The present study sought to assess oxidative imbalance and inflammation in patients with conversion disorder by examining thiol/disulfide homeostasis and CRP levels as potential biomarkers. Patients and Methods: Ninety-six patients diagnosed with Conversion Disorder according to DSM-5 criteria and ninety-six age- and sex-matched healthy controls were included. Psychiatric symptom severity was assessed using the Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI). Native thiol (SH), total thiol, disulphide levels, and ratios were measured spectrophotometrically. CRP levels were determined by immunoturbidimetry. Mann-Whitney Results: Native thiol and total thiol levels were significantly lower in CD patients compared with controls whereas disulphide levels and disulphide/thiol ratios were significantly higher (all p < 0.001). Effect sizes were large (Native thiol: d = 0.97), and post-hoc power was adequate (>0.95). No differences were observed in demographic parameters between groups. CRP levels were elevated in the CD group (2.61 ± 0.276 vs 1.34 ± 0.227 mg/L, p<0.001). Conclusion: Our findings indicate that patients with Conversion Disorder may show oxidative imbalance together with elevated CRP levels, supporting the notion that redox and inflammatory pathways could be involved in the disorder's pathophysiology. Thiol/disulfide homeostasis and CRP might therefore represent peripheral biomarkers of interest, although the cross-sectional, single-center design and the restricted set of biomarkers assessed call for cautious interpretation of these results. This is the first study to concurrently evaluate TDH and CRP in CD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.